Dr. Peter Pack Person-Info 

( Ich bin Dr. Peter Pack)

News

(1 - 4 von 42
)

How Crescendo could earn $790m from Takeda deal - Cambridgeshire Live

www.cambridge-news.co.uk
Agreement will see life sciences firm's tech licensed

Tackling the issue of exam stress - how to find help | Shropshire Star

www.shropshirestar.com
It’s the time all students and parents dread in equal measure.

Investegate |Oxford BioDynamics Announcements | Oxford BioDynamics:...

www.investegate.co.uk
Investegate announcements from Oxford BioDynamics, Board Appointments

Crescendo Biologics Announces Humabody Evaluation in CAR-T by Takeda

www.finanznachrichten.de
Dr Peter Pack, CEO of Crescendo, commented: "We're pleased to see the research Takeda is undertaking with our Humabody technology.
Dossier exportieren
+1